Cyrus Biotechnology is a cutting-edge startup based in Seattle, specializing in advanced protein engineering and computational biology. The company primarily serves clients in the biopharmaceutical, synthetic biology, chemical, non-profit, academic, and consumer product sectors. These clients range from large pharmaceutical companies developing new drugs to academic researchers studying protein structures.

Cyrus operates in the highly specialized market of protein design and optimization. The company uses sophisticated computational methods to solve complex problems in protein engineering, such as protein stabilization, difficult protein structure prediction, and enzyme optimization. Their services are crucial for clients looking to bring new products or drugs to market faster and more efficiently.

The business model of Cyrus Biotechnology is flexible and client-centric. They offer a variety of solutions tailored to the specific needs of their clients. This includes partnership models where they share risks and rewards with their clients on well-defined projects, as well as independent project support where clients can use Cyrus's tools and expertise to achieve their goals.

Cyrus makes money by providing these specialized services and solutions. They charge fees for their computational tools, consulting services, and collaborative projects. By helping their clients solve difficult protein-related problems, Cyrus adds significant value, enabling faster and more cost-effective development of new products and therapies.

In summary, Cyrus Biotechnology leverages advanced computational methods to assist a diverse range of clients in the biopharma and related industries, offering flexible business models to meet varied needs.

Keywords: Protein Engineering, Biopharma, Computational Biology, Enzyme Optimization, Drug Development, Protein Stabilization, CryoEM, Antibody Prediction, Homology Modeling, Risk Sharing.